<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Campylobacter: Infection with less common species and related bacteria
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Campylobacter: Infection with less common species and related bacteria
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Campylobacter: Infection with less common species and related bacteria
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ban M Allos, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen B Calderwood, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elinor L Baron, MD, DTMH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 26, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter
         </em>
         infection usually consists of acute enteritis caused by
         <em>
          Campylobacter jejuni
         </em>
         or
         <em>
          Campylobacter coli
         </em>
         . The genus
         <em>
          Campylobacter
         </em>
         comprises 20 species isolated from humans and many more isolated from animals. New species are identified regularly [
         <a href="#rid1">
          1
         </a>
         ]. These organisms can cause a variety of infections including intestinal, systemic, fetal/placental (abortion, stillbirth), and oral (periodontitis). Certain closely related species of
         <em>
          Arcobacter
         </em>
         and
         <em>
          Helicobacter
         </em>
         also cause human infection and may be provisionally identified as campylobacters in clinical laboratories.
        </p>
        <p>
         The clinical relevance of less common
         <em>
          Campylobacter
         </em>
         infections will be reviewed here [
         <a href="#rid2">
          2
         </a>
         ]. Issues related to
         <em>
          C. jejuni
         </em>
         and
         <em>
          C. coli
         </em>
         are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2707.html" rel="external">
          "Campylobacter infection: Microbiology, pathogenesis, and epidemiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2715.html" rel="external">
          "Campylobacter infection: Clinical manifestations, diagnosis, and treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INTESTINAL AND SYSTEMIC INFECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infections with the less common
         <em>
          Campylobacter
         </em>
         species and related organisms are observed more frequently among individuals in resource-limited settings than among individuals in developed countries [
         <a href="#rid2">
          2
         </a>
         ]. Bacteremia has been observed in the setting of malnourished children with diarrhea and patients with immunodeficiency.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Campylobacter upsaliensis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter upsaliensis
         </em>
         is the most important
         <em>
          Campylobacter
         </em>
         species after
         <em>
          C. jejuni
         </em>
         and
         <em>
          C. coli
         </em>
         [
         <a href="#rid3">
          3
         </a>
         ]. It is commonly found in younger dogs and cats, and interestingly, dogs fed homemade cooked food appear to have a higher risk of carrying this organism [
         <a href="#rid4">
          4
         </a>
         ]. These animals were once considered likely sources of human infection; however, genetic studies have demonstrated that human and canine strains are distinct [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Considerable variation in isolation rates has been reported, which may be partly due to methodologic differences rather than differences in prevalence. The selective culture media used for
         <em>
          C. jejuni
         </em>
         and
         <em>
          C. coli
         </em>
         are unsuitable for
         <em>
          C. upsaliensis
         </em>
         , which requires filtration on nonselective agar or a special selective medium.
        </p>
        <p>
         In Europe,
         <em>
          C. upsaliensis
         </em>
         comprises about 1 to 2 percent of clinical
         <em>
          Campylobacter
         </em>
         isolates. One Belgian survey noted
         <em>
          C. upsaliensis
         </em>
         comprised about 13 percent of isolates, which was likely attributable to immigrant children from Morocco and Turkey [
         <a href="#rid6">
          6
         </a>
         ]. In Cape Town,
         <em>
          C. upsaliensis
         </em>
         has been observed in 23 percent of isolates [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         <em>
          C. upsaliensis
         </em>
         infection typically causes watery diarrhea and abdominal pain, usually without fever. It is probably less pathogenic than
         <em>
          C. jejuni
         </em>
         . An outbreak among 44 children in day care centers in Brussels has been described [
         <a href="#rid7">
          7
         </a>
         ]. In an Australian study,
         <em>
          C. upsaliensis
         </em>
         was associated with prolonged diarrhea of mild to moderate severity in HIV-infected patients [
         <a href="#rid8">
          8
         </a>
         ]. Rare cases of extraintestinal infection (including isolation from a giant hepatic cyst), bacteremia, and death caused by this organism have been reported [
         <a href="#rid9">
          9-12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Campylobacter jejuni subspecies doylei
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter jejuni
         </em>
         subspecies
         <em>
          doylei
         </em>
         is a slower growing, more fastidious organism that is phylogenetically distinct from
         <em>
          C. jejuni
         </em>
         subspecies
         <em>
          jejuni
         </em>
         (referred to as
         <em>
          C. jejuni
         </em>
         ) [
         <a href="#rid13">
          13
         </a>
         ]. It requires the special filtration method for its isolation from feces and an incubation temperature of 37°C rather than 42 to 43°C.
        </p>
        <p>
         Subspecies
         <em>
          doylei
         </em>
         is generally observed among children living in resource-limited settings and is a cause of systemic infection. It was first isolated from Aboriginal Australian children and has also been identified in South African children [
         <a href="#rid2">
          2
         </a>
         ]. In Aboriginal Australian children, subspecies
         <em>
          doylei
         </em>
         accounted for 85 percent of all campylobacters isolated from blood in one series [
         <a href="#rid14">
          14
         </a>
         ]. In South African children, this organism accounted for 24 percent of blood isolates [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Most
         <em>
          C. doylei
         </em>
         strains are susceptible to both nalidixic acid and cephalothin [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Campylobacter lari
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter lari
         </em>
         shares many of the features of
         <em>
          C. jejuni
         </em>
         and
         <em>
          C. coli
         </em>
         , including the ability to grow freely at 43°C and on conventional
         <em>
          Campylobacter
         </em>
         -selective agars.
         <em>
          C. lari
         </em>
         is found in abundance in natural water and is a normal inhabitant of the intestinal tract of seagulls (genus
         <em>
          Larus
         </em>
         ), other birds, and shellfish [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         <em>
          C. lari
         </em>
         accounts for less than 1 percent of campylobacters isolated from humans. It was implicated in a water-borne outbreak of diarrhea in Canada [
         <a href="#rid16">
          16
         </a>
         ] and occasionally is isolated from blood cultures, but many strains are clearly nonpathogenic. The organism has been isolated from a patient who had experienced only a mild afebrile diarrheal illness [
         <a href="#rid17">
          17
         </a>
         ].
         <em>
          C. lari
         </em>
         has been reported as a cause of a permanent pacemaker infection [
         <a href="#rid18">
          18
         </a>
         ] and prosthetic joint infection, sepsis [
         <a href="#rid19">
          19,20
         </a>
         ], cellulitis and bacteremia in a patient with lymphoma [
         <a href="#rid21">
          21
         </a>
         ], and death in a healthy older person [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         Patients with diarrheal illness may not require antimicrobial therapy. The organism is generally susceptible to
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9241" href="/z/d/drug information/9241.html" rel="external">
          chloramphenicol
         </a>
         ,
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         , aminoglycosides, and carbapenems. Some isolates are susceptible to fluoroquinolones, but the rate of resistance is growing. A few reports have suggested
         <em>
          C. lari
         </em>
         is resistant to all cephalosporins, penicillin,
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         , and
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         [
         <a href="#rid22">
          22,23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Campylobacter hyointestinalis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter hyointestinalis
         </em>
         is normally found in the gut of pigs. It has occasionally been isolated from patients with diarrhea [
         <a href="#rid24">
          24
         </a>
         ], including a patient with infection acquired from a pig [
         <a href="#rid25">
          25
         </a>
         ]. In one series of stool isolates from South African children, it accounted for 1.3 percent of campylobacters isolated [
         <a href="#rid3">
          3
         </a>
         ].
         <em>
          C. hyointestinalis
         </em>
         also has been detected in gastric biopsy specimens of patients with gastritis but associated with less inflammation than
         <em>
          H. pylori
         </em>
         [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         The presence of hydrogen is essential for culture. In vitro and animal studies have shown that
         <em>
          C. hyointestinalis
         </em>
         is susceptible to many antimicrobial agents including
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">
          amoxicillin
         </a>
         , and
         <a class="drug drug_general" data-topicid="8676" href="/z/d/drug information/8676.html" rel="external">
          amoxicillin-clavulanate
         </a>
         [
         <a href="#rid27">
          27,28
         </a>
         ]. The organism may be resistant to
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         ,
         <a class="drug drug_general" data-topicid="10113" href="/z/d/drug information/10113.html" rel="external">
          lincomycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         , and
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         [
         <a href="#rid27">
          27,28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Campylobacter concisus
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter concisus
         </em>
         has been isolated from the stool of about 10 percent of children and adults with and without diarrhea [
         <a href="#rid2">
          2,29,30
         </a>
         ]. In some communities, this organism has been isolated with high frequency from patients with enteric illness or has been associated with prolonged diarrhea, but in the absence of a control group, no conclusion about its pathogenicity may be made [
         <a href="#rid31">
          31-35
         </a>
         ]. Evidence is accumulating that
         <em>
          C. concisus
         </em>
         may be associated with microscopic colitis and Crohn’s disease [
         <a href="#rid32">
          32,36-41
         </a>
         ]. Studies using polymerase chain reaction (PCR) assays identified the organism more frequently in the stool samples of children recently diagnosed with Crohn’s than in samples from controls [
         <a href="#rid42">
          42-44
         </a>
         ].
         <em>
          C. concisus
         </em>
         is a part of oral flora; it may contribute to the development of periodontal disease. Additionally, the organism has been identified in a brain abscess in a patient with chronic sinusitis [
         <a href="#rid45">
          45
         </a>
         ]. Bacteremia almost never occurs, probably because the organism is highly susceptible to the killing effects of normal human serum [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         Most
         <em>
          C. concisus
         </em>
         isolates are susceptible to macrolides,
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         , and
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         ; susceptibility to cephalosporins is variable [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H436256406">
         <span class="h2">
          Other campylobacters
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other subsequently identified
         <em>
          Campylobacter
         </em>
         species that may be clinically relevant include
         <em>
          C. urealyticus
         </em>
         [
         <a href="#rid48">
          48-51
         </a>
         ],
         <em>
          C. troglodytis
         </em>
         [
         <a href="#rid52">
          52
         </a>
         ],
         <em>
          C. lari
         </em>
         subspecies
         <em>
          concheus
         </em>
         ,
         <em>
          C. testudinum
         </em>
         [
         <a href="#rid53">
          53
         </a>
         ], and
         <em>
          C. peloridis
         </em>
         [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Arcobacter
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Arcobacter
         </em>
         species, including
         <em>
          A. butzleri
         </em>
         and
         <em>
          A. cryaerophilus
         </em>
         (formerly
         <em>
          A. cryaerophila
         </em>
         ), are occasionally isolated from humans. In some regions, particularly when enrichment culture techniques are used, these bacteria are identified with increasing frequency [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Both organisms cause intestinal infection; persistent watery diarrhea appears to be the main symptom [
         <a href="#rid56">
          56,57
         </a>
         ].
         <em>
          A. butzleri
         </em>
         has been reported in 2.4 percent of children with diarrhea in Thailand [
         <a href="#rid58">
          58
         </a>
         ]. It has also been isolated from the peritoneal fluid of several patients with acute appendicitis, and occasional cases of bacteremia have been reported [
         <a href="#rid56">
          56,59
         </a>
         ]. One outbreak, attributed to a single strain (Lior serogroup 1) of
         <em>
          A. butzleri
         </em>
         , affected 10 children in an Italian primary school. None of the children had diarrhea, but all suffered from intermittent abdominal cramps lasting for 5 to 10 days [
         <a href="#rid60">
          60
         </a>
         ]. In a study of 1380 persons with diarrhea in New Zealand,
         <em>
          A. butzleri
         </em>
         was isolated from seven (0.5 percent) and
         <em>
          A. cryaerophilus
         </em>
         was isolated from five (0.4 percent) [
         <a href="#rid61">
          61
         </a>
         ]. In another study of 201 travelers with diarrhea,
         <em>
          Arcobacter
         </em>
         species were isolated from the stool of 8 percent [
         <a href="#rid62">
          62
         </a>
         ]. Nevertheless, the pathogenic role of
         <em>
          Arcobacter
         </em>
         species in such studies cannot be established because they lacked an appropriate control group.
        </p>
        <p>
         <em>
          Arcobacter
         </em>
         species have also been isolated from the peritoneal fluid of several patients with acute appendicitis, and occasional cases of bacteremia have been reported [
         <a href="#rid56">
          56,57
         </a>
         ]. Patients with gastrointestinal infection typically have self-limited disease and do not require antimicrobial therapy. However, for more severe and invasive infections when antimicrobial treatment is warranted, fluoroquinolones, aminoglycosides, or tetracyclines may be used, as most in vitro studies show the organisms are susceptible to such agents [
         <a href="#rid47">
          47,63
         </a>
         ]. Most
         <em>
          A. butzleri
         </em>
         strains are susceptible to
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         , but about half of
         <em>
          A. cryaerophilus
         </em>
         are resistant to this agent [
         <a href="#rid64">
          64
         </a>
         ]. More than 20 percent of
         <em>
          Arcobacter
         </em>
         isolates are resistant to
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         and
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         [
         <a href="#rid47">
          47,63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Helicobacter cinaedi and Helicobacter fennelliae
         </span>
         <span class="headingEndMark">
          —
         </span>
         Formerly classified as campylobacters, these two species have been isolated from up to 8 percent of gay men with diarrhea or proctitis [
         <a href="#rid65">
          65
         </a>
         ]. They have also been found in South African children with diarrhea [
         <a href="#rid2">
          2
         </a>
         ]. In the latter group,
         <em>
          Helicobacter fennelliae
         </em>
         accounted for 7 percent and
         <em>
          Helicobacter cinaedi
         </em>
         0.8 percent of campylobacters isolated. Both species have caused cellulitis, osteomyelitis, infected subdural hematoma, and bacteremia, mainly in immunocompromised patients, particularly those with hematologic malignancies or HIV infection [
         <a href="#rid13">
          13,66-71
         </a>
         ].
         <em>
          H. cinaedi
         </em>
         has been identified in resected aortic aneurysms using 16S rRNA gene sequencing [
         <a href="#rid72">
          72
         </a>
         ]. There are only isolated reports of
         <em>
          H. cinaedi
         </em>
         bacteremia in immunocompetent persons [
         <a href="#rid73">
          73,74
         </a>
         ]. Recurrence of
         <em>
          H. cinaedi
         </em>
         bacteremia has been reported; in one series of 168 patients, recurrent bacteremia was identified in 20 percent and was associated with recent cancer chemotherapy or steroids [
         <a href="#rid75">
          75
         </a>
         ]. Bacterial translocation from the gastrointestinal tract in the setting of mucosal damage is a postulated mechanism for primary bacteremia. Some have also speculated that these organisms may play a role in triggering inflammatory bowel disease [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         These organisms are not associated with fatal illness, but clinical response to antimicrobial therapy is often slow and may therefore require longer courses of antimicrobial treatment. In vitro studies show the organisms are susceptible to
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         , nalidixic acid,
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9241" href="/z/d/drug information/9241.html" rel="external">
          chloramphenicol
         </a>
         , and
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         [
         <a href="#rid77">
          77
         </a>
         ]. Many isolates are resistant to
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         , and
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         . The best choice for treatment may be oral
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Other helicobacters
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are several intestinal
         <em>
          Helicobacter
         </em>
         species that have been isolated from patients with diarrhea [
         <a href="#rid2">
          2
         </a>
         ]. Their status as pathogens is difficult to assess, since routine methods of detection are unsuitable for most of them. Treatment of helicobacters that have not been definitively associated with clinical illness is not advised, as some studies suggest that certain
         <em>
          Helicobacter
         </em>
         species may exert an immunomodulatory effect that might protect against development of inflammatory bowel disease [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
         <em>
          Helicobacter westmeadii
         </em>
         was isolated from the blood of two AIDS patients with diarrhea [
         <a href="#rid80">
          80
         </a>
         ].
         <em>
          H. pullorum
         </em>
         , a species found in poultry, has been isolated from several patients with diarrhea.
         <em>
          H. canis
         </em>
         , found in dogs and similar to
         <em>
          H. fennelliae
         </em>
         , was isolated from a boy with diarrhea.
        </p>
        <p>
         <em>
          Helicobacter bilis
         </em>
         (formerly "
         <em>
          Flexispira rappini
         </em>
         ," then
         <em>
          Helicobacter rappini
         </em>
         ) has been isolated from patients with chronic diarrhea [
         <a href="#rid81">
          81
         </a>
         ]; it has also been isolated from the blood of a child with pneumonia and the blood of a man undergoing hemodialysis. Most recently it was implicated as a cause of pyoderma gangrenosum in a boy with x-linked agammaglobulinemia [
         <a href="#rid82">
          82
         </a>
         ]. This organism has a striking morphology consisting of a large fusiform body encased in spirally wound periplasmic fibers with bipolar tufts of sheathed flagella.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Campylobacter fetus
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter fetus
         </em>
         is the species most frequently associated with systemic campylobacteriosis, which generally occurs among patients with immune deficiency or other underlying disease. Systemic campylobacteriosis can also be associated with focal infection such as cellulitis or septic arthritis.
        </p>
        <p>
         There are two subspecies,
         <em>
          C. fetus
         </em>
         subspecies
         <em>
          fetus
         </em>
         and
         <em>
          C. fetus
         </em>
         subspecies
         <em>
          venerealis
         </em>
         .
         <em>
          C. fetus
         </em>
         subspecies
         <em>
          fetus
         </em>
         is the subspecies usually found in human infection (referred to as
         <em>
          C. fetus
         </em>
         ). Human infection with
         <em>
          C. fetus
         </em>
         subspecies
         <em>
          venerealis
         </em>
         is limited to a small number of case reports [
         <a href="#rid2">
          2
         </a>
         ].
         <em>
          C. fetus
         </em>
         is an important cause of abortion in sheep and cattle. Cows are infected venereally from carrier bulls with
         <em>
          C. fetus
         </em>
         subspecies
         <em>
          venerealis
         </em>
         .
         <em>
          C. fetus
         </em>
         possesses a surface layer protein (SLP) that functions as a capsule and protects the bacterium from the bactericidal action of normal serum [
         <a href="#rid83">
          83
         </a>
         ]. The SLPs are critical in virulence and undergo high-frequency phenotypic switching by recombination, resulting in antigenic variation [
         <a href="#rid84">
          84
         </a>
         ]. The antigenic variation is thought to be responsible for the ability of the organism to persist in animal and human hosts and may account for relapsing human infection despite seemingly effective antibiotic therapies. Most other campylobacters (including
         <em>
          C. jejuni
         </em>
         and
         <em>
          C. coli
         </em>
         ) do not possess SLP and are readily eliminated from the bloodstream.
        </p>
        <p>
         <em>
          C. fetus
         </em>
         is found in various animals and animal products, mainly cattle and sheep, which are probably the main source of human infection. Food-borne sources of infection likely include raw milk products, raw liver, and raw meat of such animals [
         <a href="#rid85">
          85,86
         </a>
         ]. Reports of a cluster of
         <em>
          C. fetus
         </em>
         cases among men who have sex with men suggest the possibility of person-to-person transmission [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Primary colonization takes place in the intestine, but in healthy individuals this seldom causes disease; when it does, enteritis is the primary manifestation [
         <a href="#rid3">
          3,88,89
         </a>
         ]. Human infection is uncommon and generally limited to patients with immune deficiency [
         <a href="#rid90">
          90
         </a>
         ]. Predisposing factors include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver disease (particularly alcoholic cirrhosis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignancy, leukemia, and other blood dyscrasias
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diabetes mellitus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         AIDS and other immune deficiency states
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Older subjects
        </p>
        <p>
        </p>
        <p>
         Such patients usually present with a nonspecific febrile illness. Localizing signs are usually absent, and the first indication of the nature of the illness is isolation of
         <em>
          C. fetus
         </em>
         from the blood.
         <em>
          C. fetus
         </em>
         has a tropism for endovascular tissue, so endocarditis [
         <a href="#rid90">
          90
         </a>
         ], infected aneurysms [
         <a href="#rid91">
          91,92
         </a>
         ], or septic thrombophlebitis may be observed. Other forms of focal infection can occur; these include meningoencephalitis, osteomyelitis, empyema, cholecystitis, pericarditis, myocarditis, peritonitis, and salpingitis [
         <a href="#rid2">
          2,93
         </a>
         ].
        </p>
        <p>
         Healthy persons who develop
         <em>
          C. fetus
         </em>
         gastroenteritis will usually recover without antibiotic therapy. However, immunocompromised persons or those with bacteremia or other extraintestinal infection may require a prolonged course of antimicrobial treatment. The organism is generally susceptible to
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         , third-generation cephalosporins, aminoglycosides,
         <a class="drug drug_general" data-topicid="8553" href="/z/d/drug information/8553.html" rel="external">
          imipenem
         </a>
         , and
         <a class="drug drug_general" data-topicid="9613" href="/z/d/drug information/9613.html" rel="external">
          meropenem
         </a>
         ; these agents have been used effectively [
         <a href="#rid94">
          94-96
         </a>
         ]. As an example, in a small series of patients with
         <em>
          C. fetus
         </em>
         bacteremia, all of six patients treated with imipenem and 7 of 11 treated with
         <a class="drug drug_general" data-topicid="8676" href="/z/d/drug information/8676.html" rel="external">
          amoxicillin-clavulanate
         </a>
         had favorable outcomes [
         <a href="#rid94">
          94
         </a>
         ]. In contrast, use of fluoroquinolones was associated with death in a separate series of 94 cases of
         <em>
          C. fetus
         </em>
         bacteremia, among which the fluoroquinolone resistance rate was 33 percent [
         <a href="#rid89">
          89
         </a>
         ]. Because many isolates are resistant,
         <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">
          erythromycin
         </a>
         should not be used [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
         There are no therapeutic trials on which to base treatment duration recommendations. Endovascular infections should probably be treated for at least four weeks. Infection of the central nervous system should be treated for at least two to three weeks. Persistent or relapsing infection with
         <em>
          C. fetus
         </em>
         can occur, even years after the initial diagnosis [
         <a href="#rid84">
          84,86
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          FETAL/PLACENTAL INFECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Campylobacter enteritis
         </em>
         during pregnancy occurs with relative frequency; a very small proportion of fetuses are affected. Approximately 30 instances of
         <em>
          Campylobacter
         </em>
         abortion, stillbirth, or congenital infection have been described [
         <a href="#rid97">
          97
         </a>
         ]; roughly half are due to
         <em>
          C. fetus
         </em>
         , half to
         <em>
          C. jejuni
         </em>
         , and one each to
         <em>
          C. coli
         </em>
         and
         <em>
          C. upsaliensis
         </em>
         [
         <a href="#rid98">
          98
         </a>
         ]. The stage of gestation ranged from 10 weeks to full term (average 19 weeks for
         <em>
          C. jejuni
         </em>
         , 28 weeks for
         <em>
          C. fetus
         </em>
         ). It is probable that many gestational infections go undetected.
        </p>
        <p>
         Infected pregnant women typically present with fever, with or without vaginal bleeding. Abortion can also occur without antecedent symptoms. Abdominal pain with or without diarrhea is present in at least half of patients with
         <em>
          C. jejuni
         </em>
         . Hematogenous spread from the gut is probably the main route of placental infection. Inflammation of the placenta with necrosis is almost always present.
         <em>
          Campylobacter
         </em>
         organisms can be isolated from blood cultures and from placental and fetal tissues. Ascending genital tract infection may occur in some cases [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
         In the setting of
         <em>
          C. fetus
         </em>
         infection, the fetal outcome is frequently death; survival is possible if the agent is
         <em>
          C. jejuni
         </em>
         and infection is at or near term [
         <a href="#rid97">
          97
         </a>
         ]. Intrauterine infection at term may be difficult to distinguish from perinatal infection acquired during delivery from a mother with stool shedding of organisms. In such cases, the prognosis is relatively good with appropriate treatment, even in the setting of meningitis.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          PERIODONTAL INFECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Six species of
         <em>
          Campylobacter
         </em>
         are part of the human oral flora:
         <em>
          C. sputorum
         </em>
         ,
         <em>
          C. concisus
         </em>
         ,
         <em>
          C. rectus
         </em>
         ,
         <em>
          C. curvus
         </em>
         ,
         <em>
          C. showae
         </em>
         , and
         <em>
          C. gracilis
         </em>
         [
         <a href="#rid100">
          100
         </a>
         ].
         <em>
          C. rectus
         </em>
         (formerly
         <em>
          Wolinella recta
         </em>
         ) has a particularly strong association with periodontal infection and has a protective surface S-layer protein (as described above for
         <em>
          C. fetus
         </em>
         ) [
         <a href="#rid101">
          101
         </a>
         ]. Patients with periodontitis have a higher titer of IgG antibody to this protein than controls [
         <a href="#rid102">
          102
         </a>
         ]. Cytotoxin production by
         <em>
          C. rectus
         </em>
         has also been reported [
         <a href="#rid103">
          103
         </a>
         ]. (See
         <a class="local">
          'Campylobacter fetus'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H666988976">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109942.html" rel="external">
          "Society guideline links: Acute diarrhea in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4591708">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The genus
         <em>
          Campylobacter
         </em>
         comprises 20 species isolated from humans. These organisms can cause a variety of infections including intestinal, systemic, fetal/placental (abortion, stillbirth), and oral (periodontitis). Certain closely related species of
         <em>
          Arcobacter
         </em>
         and
         <em>
          Helicobacter
         </em>
         also cause human infection and may be provisionally identified as campylobacters in clinical laboratories. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infections with the less common
         <em>
          Campylobacter
         </em>
         species and related organisms are observed more frequently among individuals in resource-limited settings than among individuals in developed countries.
         <em>
          Campylobacter upsaliensis
         </em>
         is the most prevalent
         <em>
          Campylobacter
         </em>
         species after
         <em>
          C. jejuni
         </em>
         and
         <em>
          C. coli
         </em>
         .
         <em>
          C. jejuni
         </em>
         subspecies
         <em>
          doylei
         </em>
         is a slower growing, more fastidious organism than
         <em>
          C. jejuni
         </em>
         subspecies
         <em>
          jejuni
         </em>
         (referred to as
         <em>
          C. jejuni
         </em>
         ). (See
         <a class="local">
          'Intestinal and systemic infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Campylobacter fetus
         </em>
         is the species most frequently associated with systemic campylobacteriosis, which generally occurs among patients with immune deficiency or other underlying disease.
         <em>
          C. fetus
         </em>
         is found in various animals and animal products, which are probably the main source of human infection. Patients usually present with a nonspecific febrile illness.
         <em>
          C. fetus
         </em>
         has a tropism for endovascular tissue, so endocarditis, infected aneurysms, or septic thrombophlebitis may be observed. (See
         <a class="local">
          'Campylobacter fetus'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Approximately 30 instances of
         <em>
          Campylobacter
         </em>
         abortion, stillbirth, or congenital infection have been described. Infected pregnant women typically present with fever, with or without vaginal bleeding. Abortion can also occur without antecedent symptoms. Hematogenous spread from the gut is probably the main route of placental infection.
         <em>
          Campylobacter
         </em>
         organisms can be isolated from blood cultures and from placental and fetal tissues. In the setting of
         <em>
          C. fetus
         </em>
         infection, the fetal outcome is frequently death; survival is possible if the agent is
         <em>
          C. jejuni
         </em>
         and infection is at or near term. (See
         <a class="local">
          'Fetal/placental infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Six species of
         <em>
          Campylobacter
         </em>
         are part of the human oral flora:
         <em>
          C. sputorum
         </em>
         ,
         <em>
          C. concisus
         </em>
         ,
         <em>
          C. rectus
         </em>
         ,
         <em>
          C. curvus
         </em>
         ,
         <em>
          C. showae
         </em>
         , and
         <em>
          C. gracilis
         </em>
         .
         <em>
          C. rectus
         </em>
         (formerly
         <em>
          Wolinella recta
         </em>
         ) has a particularly strong association with periodontal infection. (See
         <a class="local">
          'Periodontal infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enteric infections due to
         <em>
          Campylobacter
         </em>
         and related species do not necessarily warrant antimicrobial therapy. For patients with severe or systemic infection, antimicrobial therapy should be tailored to antibiotic susceptibility testing. The typical susceptibility profile varies by species. (See
         <a class="local">
          'Intestinal and systemic infection'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Lastovica A J, Allos BM. Clinical significance of Campylobacter and related species other than Campylobacter jejuni and Campylobacter coli. In: Campylobacter, 3rd Ed, Nachamkin I, Szymanski CM, Blaser MJ (Eds), American Society for Microbiology, Washington, DC 2008. p.123.
         </li>
         <li class="breakAll">
          Lastovica AJ, Engel ME, Blaser MJ. Atypical campylobacters and related microorganisms. In: Infections of the Gastrointestinal Tract, 2nd Ed, Blaser MJ, Smith PD, Ravdin JI, et al (Eds), Lippincott Williams and Wilkins, Philadelphia 2002. p.741.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bourke B, Chan VL, Sherman P. Campylobacter upsaliensis: waiting in the wings. Clin Microbiol Rev 1998; 11:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leonard EK, Pearl DL, Janecko N, et al. Factors related to Campylobacter spp. carriage in client-owned dogs visiting veterinary clinics in a region of Ontario, Canada. Epidemiol Infect 2011; 139:1531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Damborg P, Guardabassi L, Pedersen K, Kokotovic B. Comparative analysis of human and canine Campylobacter upsaliensis isolates by amplified fragment length polymorphism. J Clin Microbiol 2008; 46:1504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goossens H, Vlaes L, De Boeck M, et al. Is "Campylobacter upsaliensis" an unrecognised cause of human diarrhoea? Lancet 1990; 335:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goossens H, Giesendorf BA, Vandamme P, et al. Investigation of an outbreak of Campylobacter upsaliensis in day care centers in Brussels: analysis of relationships among isolates by phenotypic and genotypic typing methods. J Infect Dis 1995; 172:1298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jenkin GA, Tee W. Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients. Clin Infect Dis 1998; 27:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lastovica AJ, Le Roux E. Prevalence and distribution of Campylobacter spp. in the diarrhoeic stools and blood cultures of pediatric patients. Acta Gastroenterol Belg 1993; 56:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patton CM, Shaffer N, Edmonds P, et al. Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States. J Clin Microbiol 1989; 27:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakamura I, Omori N, Umeda A, et al. First case report of fatal sepsis due to Campylobacter upsaliensis. J Clin Microbiol 2015; 53:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohkoshi Y, Sato T, Murabayashi H, et al. Campylobacter upsaliensis isolated from a giant hepatic cyst. J Infect Chemother 2020; 26:752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker CT, Miller WG, Horn ST, Lastovica AJ. Common genomic features of Campylobacter jejuni subsp. doylei strains distinguish them from C. jejuni subsp. jejuni. BMC Microbiol 2007; 7:50.
          </a>
         </li>
         <li class="breakAll">
          Morey F. Five years of Campylobacter bacteraemia in central Australia. In: Campylobacters, Helicobacters, and Related Organisms, Newell DG, Ketley JM, Feldman RA (Eds), Plenum Press, New York 1996. p.491.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keller JI, Shriver WG, Waldenström J, et al. Prevalence of Campylobacter in wild birds of the mid-Atlantic region, USA. J Wildl Dis 2011; 47:750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broczyk A, Thompson S, Smith D, Lior H. Water-borne outbreak of Campylobacter laridis-associated gastroenteritis. Lancet 1987; 1:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campion E, Pitt TL, McDonald CP, Brailsford SR. Campylobacter lari in a platelet donation: an unexpected finding. Transfus Med 2014; 24:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris CN, Scully B, Garvey GJ. Campylobacter lari associated with permanent pacemaker infection and bacteremia. Clin Infect Dis 1998; 27:220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Werno AM, Klena JD, Shaw GM, Murdoch DR. Fatal case of Campylobacter lari prosthetic joint infection and bacteremia in an immunocompetent patient. J Clin Microbiol 2002; 40:1053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morishita S, Fujiwara H, Murota H, et al. Bloodstream infection caused by Campylobacter lari. J Infect Chemother 2013; 19:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyamatsu Y, Tanizaki R, Yamada S, et al. Cellulitis with persistent bacteremia caused by Campylobacter lari in a patient with mantle-cell lymphoma. IDCases 2021; 23:e01053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans TG, Riley D. Campylobacter laridis colitis in a human immunodeficiency virus-positive patient treated with a quinolone. Clin Infect Dis 1992; 15:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simor AE, Wilcox L. Enteritis associated with Campylobacter laridis. J Clin Microbiol 1987; 25:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edmonds P, Patton CM, Griffin PM, et al. Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol 1987; 25:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorkiewicz G, Feierl G, Zechner R, Zechner EL. Transmission of Campylobacter hyointestinalis from a pig to a human. J Clin Microbiol 2002; 40:2601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seo TH, Lee SY, Uchida T, et al. The origin of non-H. pylori-related positive Giemsa staining in human gastric biopsy specimens: A prospective study. Dig Liver Dis 2011; 43:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laatu M, Rautelin H, Hänninen ML. Susceptibility of Campylobacter hyointestinalis subsp. hyointestinalis to antimicrobial agents and characterization of quinolone-resistant strains. J Antimicrob Chemother 2005; 55:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inglis GD, McAllister TA, Busz HW, et al. Effects of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis. Appl Environ Microbiol 2005; 71:3872.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Etterijck R, Breynaert J, Revets H, et al. Isolation of Campylobacter concisus from feces of children with and without diarrhea. J Clin Microbiol 1996; 34:2304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tilmanne A, Martiny D, Hallin M, et al. Campylobacter Concisus and Acute Gastroenteritis in Children: Lack of Association. Pediatr Infect Dis J 2018; 37:e339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aabenhus R, Permin H, On SL, Andersen LP. Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients. Scand J Infect Dis 2002; 34:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hess DL, Pettersson AM, Rijnsburger MC, et al. Gastroenteritis caused by Campylobacter concisus. J Med Microbiol 2012; 61:746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keenan JI, Leaman JD, Greenlees R, Day AS. Is Campylobacter consisus an unrecognised cause of diarrhoea in New Zealand? N Z Med J 2014; 127:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Clinical manifestations of Campylobacter concisus infection in children. Pediatr Infect Dis J 2013; 32:1194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen HL, Engberg J, Ejlertsen T, et al. Short-term and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect 2012; 18:E459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ismail Y, Mahendran V, Octavia S, et al. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One 2012; 7:e38217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kovach Z, Kaakoush NO, Lamb S, et al. Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen. FEMS Immunol Med Microbiol 2011; 63:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahendran V, Riordan SM, Grimm MC, et al. Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One 2011; 6:e25417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang L. Oral Campylobacter species: Initiators of a subgroup of inflammatory bowel disease? World J Gastroenterol 2015; 21:9239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yde Aagaard ME, Frahm Kirk K, Linde Nielsen H, et al. Campylobacter concisus is prevalent in the gastrointestinal tract of patients with microscopic colitis. Scand J Gastroenterol 2020; 55:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen HL, Dalager-Pedersen M, Nielsen H. High risk of microscopic colitis after Campylobacter concisus infection: population-based cohort study. Gut 2020; 69:1952.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Man SM, Zhang L, Day AS, et al. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis 2010; 16:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang L, Man SM, Day AS, et al. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 2009; 47:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lastovica AJ. Clinical relevance of Campylobacter concisus isolated from pediatric patients. J Clin Microbiol 2009; 47:2360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Vries JJ, Arents NL, Manson WL. Campylobacter species isolated from extra-oro-intestinal abscesses: a report of four cases and literature review. Eur J Clin Microbiol Infect Dis 2008; 27:1119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirk KF, Nielsen HL, Nielsen H. The susceptibility of Campylobacter concisus to the bactericidal effects of normal human serum. APMIS 2015; 123:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandenberg O, Houf K, Douat N, et al. Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium. J Antimicrob Chemother 2006; 57:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burgos-Portugal JA, Kaakoush NO, Raftery MJ, Mitchell HM. Pathogenic potential of Campylobacter ureolyticus. Infect Immun 2012; 80:883.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011; 8:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bullman S, Corcoran D, O'Leary J, et al. Campylobacter ureolyticus: an emerging gastrointestinal pathogen? FEMS Immunol Med Microbiol 2011; 61:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Donovan D, Corcoran GD, Lucey B, Sleator RD. Campylobacter ureolyticus: a portrait of the pathogen. Virulence 2014; 5:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaur T, Singh J, Huffman MA, et al. Campylobacter troglodytis sp. nov., isolated from feces of human-habituated wild chimpanzees (Pan troglodytes schweinfurthii) in Tanzania. Appl Environ Microbiol 2011; 77:2366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patrick ME, Gilbert MJ, Blaser MJ, et al. Human infections with new subspecies of Campylobacter fetus. Emerg Infect Dis 2013; 19:1678.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Debruyne L, On SL, De Brandt E, Vandamme P. Novel Campylobacter lari-like bacteria from humans and molluscs: description of Campylobacter peloridis sp. nov., Campylobacter lari subsp. concheus subsp. nov. and Campylobacter lari subsp. lari subsp. nov. Int J Syst Evol Microbiol 2009; 59:1126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van den Abeele AM, Vogelaers D, Van Hende J, Houf K. Prevalence of Arcobacter species among humans, Belgium, 2008-2013. Emerg Infect Dis 2014; 20:1731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansfield LP, Forsythe SJ. Arcobacter butzleri, A. skirrowii and A. cryaerophilus--potential emerging human pathogens. Rev Med Microbiol 2000; 11:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collado L, Figueras MJ. Taxonomy, epidemiology, and clinical relevance of the genus Arcobacter. Clin Microbiol Rev 2011; 24:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor DN, Kiehlbauch JA, Tee W, et al. Isolation of group 2 aerotolerant Campylobacter species from Thai children with diarrhea. J Infect Dis 1991; 163:1062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arguello E, Otto CC, Mead P, Babady NE. Bacteremia caused by Arcobacter butzleri in an immunocompromised host. J Clin Microbiol 2015; 53:1448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandamme P, Pugina P, Benzi G, et al. Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school. J Clin Microbiol 1992; 30:2335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandisodza O, Burrows E, Nulsen M. Arcobacter species in diarrhoeal faeces from humans in New Zealand. N Z Med J 2012; 125:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang ZD, Dupont HL, Brown EL, et al. Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species. J Clin Microbiol 2010; 48:1417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kabeya H, Maruyama S, Morita Y, et al. Prevalence of Arcobacter species in retail meats and antimicrobial susceptibility of the isolates in Japan. Int J Food Microbiol 2004; 90:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van den Abeele AM, Vogelaers D, Vanlaere E, Houf K. Antimicrobial susceptibility testing of Arcobacter butzleri and Arcobacter cryaerophilus strains isolated from Belgian patients. J Antimicrob Chemother 2016; 71:1241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laughon BE, Vernon AA, Druckman DA, et al. Recovery of Campylobacter species from homosexual men. J Infect Dis 1988; 158:464.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minauchi K, Takahashi S, Sakai T, et al. The nosocomial transmission of Helicobacter cinaedi infections in immunocompromised patients. Intern Med 2010; 49:1733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saito S, Tsukahara M, Ohkusu K, Kurai H. Helicobacter fennelliae Bacteremia: Three Case Reports and Literature Review. Medicine (Baltimore) 2016; 95:e3556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Araoka H, Baba M, Kimura M, et al. Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive. J Clin Microbiol 2014; 52:1519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pérez-Santiago J, Ramirez-Gaona M, Holm-Kennedy R, et al. Bacteremia and Skin Infections in Four Patients Caused by Helicobacter-Like Organisms. Open Forum Infect Dis 2017; 4:ofx074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inoue K, Sasaki S, Yasumi T, et al. Helicobacter cinaedi-Associated Refractory Cellulitis in Patients with X-Linked Agammaglobulinemia. J Clin Immunol 2020; 40:1132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akiyama T, Imamura H, Fukui N, Sakai N. Helicobacter cinaedi-infected chronic subdural hematoma mimicking an expanding hematoma: A case report. Surg Neurol Int 2021; 12:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsuo T, Mori N, Mizuno A, et al. Infected aortic aneurysm caused by Helicobacter cinaedi: case series and systematic review of the literature. BMC Infect Dis 2020; 20:854.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fox-Lewis A, Basu I, Vesty A, et al. Helicobacter cinaedi bacteremia in a returning traveler. IDCases 2020; 21:e00910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen SL, Ørsted I, Tarpgaard IH, Nielsen HL. Helicobacter cinaedi bacteraemia secondary to enterocolitis in an immunocompetent patient. Gut Pathog 2021; 13:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Araoka H, Baba M, Okada C, et al. Risk Factors for Recurrent Helicobacter cinaedi Bacteremia and the Efficacy of Selective Digestive Decontamination With Kanamycin to Prevent Recurrence. Clin Infect Dis 2018; 67:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen R, Thomson JM, Fox JG, et al. Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol 2011; 61:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore JE, Barton MD, Blair IS, et al. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 2006; 8:1955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burman WJ, Cohn DL, Reves RR, Wilson ML. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis 1995; 20:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut 2017; 66:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trivett-Moore NL, Rawlinson WD, Yuen M, Gilbert GL. Helicobacter westmeadii sp. nov., a new species isolated from blood cultures of two AIDS patients. J Clin Microbiol 1997; 35:1144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romero S, Archer JR, Hamacher ME, et al. Case report of an unclassified microaerophilic bacterium associated with gastroenteritis. J Clin Microbiol 1988; 26:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murray PR, Jain A, Uzel G, et al. Pyoderma gangrenosum-like ulcer in a patient with X-linked agammaglobulinemia: identification of Helicobacter bilis by mass spectrometry analysis. Arch Dermatol 2010; 146:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blaser MJ, Smith PF, Repine JE, Joiner KA. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. J Clin Invest 1988; 81:1434.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tu ZC, Gaudreau C, Blaser MJ. Mechanisms underlying Campylobacter fetus pathogenesis in humans: surface-layer protein variation in relapsing infections. J Infect Dis 2005; 191:2082.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control (CDC). Campylobacter sepsis associated with "nutritional therapy"--California. MMWR Morb Mortal Wkly Rep 1981; 30:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagenaar JA, van Bergen MA, Blaser MJ, et al. Campylobacter fetus infections in humans: exposure and disease. Clin Infect Dis 2014; 58:1579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchand-Senécal X, Bekal S, Pilon PA, et al. Campylobacter fetus Cluster Among Men Who Have Sex With Men, Montreal, Quebec, Canada, 2014-2016. Clin Infect Dis 2017; 65:1751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennie RP, Strong D, Taylor DE, et al. Campylobacter fetus diarrhea in a Hutterite colony: epidemiological observations and typing of the causative organism. J Clin Microbiol 1994; 32:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pacanowski J, Lalande V, Lacombe K, et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis 2008; 47:790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farrugia DC, Eykyn SJ, Smyth EG. Campylobacter fetus endocarditis: two case reports and review. Clin Infect Dis 1994; 18:443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montero A, Corbella X, López JA, et al. Campylobacter fetus-associated aneurysms: report of a case involving the popliteal artery and review of the literature. Clin Infect Dis 1997; 24:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagiya H, Matsumoto M, Furukawa H, et al. Mycotic abdominal aortic aneurysm caused by Campylobacter fetus: a case report and literature review. Ann Vasc Surg 2014; 28:1933.e7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uzoigwe C. Campylobacter infections of the pericardium and myocardium. Clin Microbiol Infect 2005; 11:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gazaigne L, Legrand P, Renaud B, et al. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis 2008; 27:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000. J Clin Microbiol 2003; 41:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujihara N, Takakura S, Saito T, et al. A case of perinatal sepsis by Campylobacter fetus subsp. fetus infection successfully treated with carbapenem--case report and literature review. J Infect 2006; 53:e199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong SN, Tam AY, Yuen KY. Campylobacter infection in the neonate: case report and review of the literature. Pediatr Infect Dis J 1990; 9:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gurgan T, Diker KS. Abortion associated with Campylobacter upsaliensis. J Clin Microbiol 1994; 32:3093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simor AE, Karmali MA, Jadavji T, Roscoe M. Abortion and perinatal sepsis associated with campylobacter infection. Rev Infect Dis 1986; 8:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams RC. Periodontal disease. N Engl J Med 1990; 322:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rams TE, Feik D, Slots J. Campylobacter rectus in human periodontitis. Oral Microbiol Immunol 1993; 8:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kokeguchi S, Kato K, Kurihara H, Murayama Y. Cell surface protein antigen from Wolinella recta ATCC 33238T. J Clin Microbiol 1989; 27:1210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillespie J, De Nardin E, Radel S, et al. Production of an extracellular toxin by the oral pathogen Campylobacter rectus. Microb Pathog 1992; 12:69.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2716 Version 29.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Lastovica A J, Allos BM. Clinical significance of Campylobacter and related species other than Campylobacter jejuni and Campylobacter coli. In: Campylobacter, 3rd Ed, Nachamkin I, Szymanski CM, Blaser MJ (Eds), American Society for Microbiology, Washington, DC 2008. p.123.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Lastovica AJ, Engel ME, Blaser MJ. Atypical campylobacters and related microorganisms. In: Infections of the Gastrointestinal Tract, 2nd Ed, Blaser MJ, Smith PD, Ravdin JI, et al (Eds), Lippincott Williams and Wilkins, Philadelphia 2002. p.741.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9665977" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Campylobacter upsaliensis: waiting in the wings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21208515" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Factors related to Campylobacter spp. carriage in client-owned dogs visiting veterinary clinics in a region of Ontario, Canada.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18287320" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Comparative analysis of human and canine Campylobacter upsaliensis isolates by amplified fragment length polymorphism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1968583" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Is "Campylobacter upsaliensis" an unrecognised cause of human diarrhoea?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7594667" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Investigation of an outbreak of Campylobacter upsaliensis in day care centers in Brussels: analysis of relationships among isolates by phenotypic and genotypic typing methods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9798039" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Prevalence and distribution of Campylobacter spp. in the diarrhoeic stools and blood cultures of pediatric patients
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2913038" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25411172" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : First case report of fatal sepsis due to Campylobacter upsaliensis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32199791" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Campylobacter upsaliensis isolated from a giant hepatic cyst.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17535437" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Common genomic features of Campylobacter jejuni subsp. doylei strains distinguish them from C. jejuni subsp. jejuni.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17535437" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Common genomic features of Campylobacter jejuni subsp. doylei strains distinguish them from C. jejuni subsp. jejuni.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21719846" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Prevalence of Campylobacter in wild birds of the mid-Atlantic region, USA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2880002" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Water-borne outbreak of Campylobacter laridis-associated gastroenteritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25041073" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Campylobacter lari in a platelet donation: an unexpected finding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9675486" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Campylobacter lari associated with permanent pacemaker infection and bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11880437" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Fatal case of Campylobacter lari prosthetic joint infection and bacteremia in an immunocompetent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22965843" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Bloodstream infection caused by Campylobacter lari.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33537208" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Cellulitis with persistent bacteremia caused by Campylobacter lari in a patient with mantle-cell lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1319755" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Campylobacter laridis colitis in a human immunodeficiency virus-positive patient treated with a quinolone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3793864" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Enteritis associated with Campylobacter laridis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3571477" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12089284" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Transmission of Campylobacter hyointestinalis from a pig to a human.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20483675" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The origin of non-H. pylori-related positive Giemsa staining in human gastric biopsy specimens: A prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15649999" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Susceptibility of Campylobacter hyointestinalis subsp. hyointestinalis to antimicrobial agents and characterization of quinolone-resistant strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16000800" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Effects of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8862606" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Isolation of Campylobacter concisus from feces of children with and without diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29601450" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Campylobacter Concisus and Acute Gastroenteritis in Children: Lack of Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12064685" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22301611" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Gastroenteritis caused by Campylobacter concisus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24732257" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Is Campylobacter consisus an unrecognised cause of diarrhoea in New Zealand?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23743545" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Clinical manifestations of Campylobacter concisus infection in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22882347" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Short-term and medium-term clinical outcomes of Campylobacter concisus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22666490" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22092566" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21966525" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26309350" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Oral Campylobacter species: Initiators of a subgroup of inflammatory bowel disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32667235" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Campylobacter concisus is prevalent in the gastrointestinal tract of patients with microscopic colitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32111632" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : High risk of microscopic colitis after Campylobacter concisus infection: population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19885905" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19052183" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19574589" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Clinical relevance of Campylobacter concisus isolated from pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18488257" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Campylobacter species isolated from extra-oro-intestinal abscesses: a report of four cases and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25627875" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : The susceptibility of Campylobacter concisus to the bactericidal effects of normal human serum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16533825" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22124656" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Pathogenic potential of Campylobacter ureolyticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22025030" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : The clinical importance of emerging Campylobacter species.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21320172" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Campylobacter ureolyticus: an emerging gastrointestinal pathogen?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24717836" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Campylobacter ureolyticus: a portrait of the pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21278267" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Campylobacter troglodytis sp. nov., isolated from feces of human-habituated wild chimpanzees (Pan troglodytes schweinfurthii) in Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24050521" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Human infections with new subspecies of Campylobacter fetus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19406805" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Novel Campylobacter lari-like bacteria from humans and molluscs: description of Campylobacter peloridis sp. nov., Campylobacter lari subsp. concheus subsp. nov. and Campylobacter lari subsp. lari subsp. nov.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25271569" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Prevalence of Arcobacter species among humans, Belgium, 2008-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Arcobacter butzleri, A. skirrowii and A. cryaerophilus--potential emerging human pathogens
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21233511" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Taxonomy, epidemiology, and clinical relevance of the genus Arcobacter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2019754" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Isolation of group 2 aerotolerant Campylobacter species from Thai children with diarrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25673792" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Bacteremia caused by Arcobacter butzleri in an immunocompromised host.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1400998" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22522270" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Arcobacter species in diarrhoeal faeces from humans in New Zealand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20107088" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14751685" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Prevalence of Arcobacter species in retail meats and antimicrobial susceptibility of the isolates in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26851610" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Antimicrobial susceptibility testing of Arcobacter butzleri and Arcobacter cryaerophilus strains isolated from Belgian patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3403996" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Recovery of Campylobacter species from homosexual men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20720350" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The nosocomial transmission of Helicobacter cinaedi infections in immunocompromised patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27149471" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Helicobacter fennelliae Bacteremia: Three Case Reports and Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24574294" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31338379" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Bacteremia and Skin Infections in Four Patients Caused by Helicobacter-Like Organisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32914284" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Helicobacter cinaedi-Associated Refractory Cellulitis in Patients with X-Linked Agammaglobulinemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34221619" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Helicobacter cinaedi-infected chronic subdural hematoma mimicking an expanding hematoma: A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33203370" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Infected aortic aneurysm caused by Helicobacter cinaedi: case series and systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32695610" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Helicobacter cinaedi bacteremia in a returning traveler.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33888153" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Helicobacter cinaedi bacteraemia secondary to enterocolitis in an immunocompetent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29462291" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Risk Factors for Recurrent Helicobacter cinaedi Bacteremia and the Efficacy of Selective Digestive Decontamination With Kanamycin to Prevent Recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20955468" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Could Helicobacter organisms cause inflammatory bowel disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16716632" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : The epidemiology of antibiotic resistance in Campylobacter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7756476" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26508508" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9114397" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Helicobacter westmeadii sp. nov., a new species isolated from blood cultures of two AIDS patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3343307" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Case report of an unclassified microaerophilic bacterium associated with gastroenteritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20479300" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Pyoderma gangrenosum-like ulcer in a patient with X-linked agammaglobulinemia: identification of Helicobacter bilis by mass spectrometry analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3366901" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15897994" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Mechanisms underlying Campylobacter fetus pathogenesis in humans: surface-layer protein variation in relapsing infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6789105" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Campylobacter sepsis associated with "nutritional therapy"--California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24550377" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Campylobacter fetus infections in humans: exposure and disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29020280" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Campylobacter fetus Cluster Among Men Who Have Sex With Men, Montreal, Quebec, Canada, 2014-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7910829" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Campylobacter fetus diarrhea in a Hutterite colony: epidemiological observations and typing of the causative organism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18699745" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Campylobacter bacteremia: clinical features and factors associated with fatal outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8011832" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Campylobacter fetus endocarditis: two case reports and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9142823" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Campylobacter fetus-associated aneurysms: report of a case involving the popliteal artery and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25017776" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Mycotic abdominal aortic aneurysm caused by Campylobacter fetus: a case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15760422" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Campylobacter infections of the pericardium and myocardium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17999095" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Campylobacter fetus bloodstream infection: risk factors and clinical features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12517895" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16542730" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : A case of perinatal sepsis by Campylobacter fetus subsp. fetus infection successfully treated with carbapenem--case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2235192" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Campylobacter infection in the neonate: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7883913" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Abortion associated with Campylobacter upsaliensis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3523697" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Abortion and perinatal sepsis associated with campylobacter infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2405268" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Periodontal disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8247610" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Campylobacter rectus in human periodontitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2753998" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Cell surface protein antigen from Wolinella recta ATCC 33238T.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1560755" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Production of an extracellular toxin by the oral pathogen Campylobacter rectus.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
